As of November 6, 2026, Clearmind Medicine Inc. is a publicly traded company (Nasdaq: CMND); its largest reported holder is Iroquois Capital Management, LLC, with 9.99% on Schedule 13G/A of August 12, 2026, then Richard Abbe (9.99%). The largest insider holding is HRT Financial LP, a 10% owner, with 81,353 shares (51.5% of shares outstanding), per Form 4 of June 18, 2026 (Schedule 13G/A, August 12, 2026).
Is this your company?
About to sign with, pay or invest in Clearmind Medicine Inc.? See the free Snapshot first.
Free to see. No signup.
Is Clearmind Medicine Inc. a real, registered company?
- Clearmind Medicine Inc. files with the SEC under CIK 1892500 (its SEC filings).
- Its shares are listed under the ticker CMND on Nasdaq (SEC company record).
- Incorporated in Z4; business address in Vancouver, British Columbia, Z4, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Clearmind Medicine Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Iroquois Capital Management, LLC (filed 2026-08-12).
Who are Clearmind Medicine Inc.'s owners and officers?
Clearmind Medicine Inc.: business address in Vancouver, British Columbia, Z4; industry Pharmaceutical Preparations (Schedule 13G, 2026-10-27).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer (Form D, 2024-02-07)
- : Executive Officer (Form D, 2024-02-07)
- : Executive Officer (Form D, 2024-02-07)
- : Director (Form D, 2024-02-07)
- : Director (Form D, 2024-02-07)
- : Director (Form D, 2024-02-07)
- : Director (Form D, 2024-02-07)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-27 | Gainor Lewis Berray | 4.9% |
| Schedule 13G/A, 2026-08-12 | Iroquois Capital Management, LLC | 9.99% |
| Schedule 13G/A, 2026-05-15 | Capitalink LTD. | 0% |
| Schedule 13G/A, 2026-05-15 | L.I.A. Pure Capital LTD. | 0% |
| Schedule 13G/A, 2026-03-16 | Capitalink LTD. | 5% |
| Schedule 13G/A, 2026-03-16 | L.I.A. Pure Capital LTD. | 5% |
| Schedule 13G/A, 2026-03-09 | Nissim Daniel | 0% |
| Schedule 13G/A, 2026-02-17 | Richard Abbe | 9.99% |
| Schedule 13G/A, 2025-12-10 | Capitalink LTD. | 9.97% |
| Schedule 13G/A, 2025-12-10 | L.I.A. Pure Capital LTD. | 9.97% |
| Schedule 13G, 2025-12-01 | Capitalink LTD. | 9.99% |
| Schedule 13G, 2025-12-01 | L.I.A. Pure Capital LTD. | 9.99% |
Questions about who owns Clearmind Medicine Inc.
Who owns Clearmind Medicine Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Clearmind Medicine Inc.: Iroquois Capital Management, LLC (9.99%, Schedule 13G/A, filed 2026-08-12) and Richard Abbe (9.99%, Schedule 13G/A, filed 2026-02-17).
Who are the largest shareholders of Clearmind Medicine Inc.?
By the share each holder's latest filing reports, the largest holders of Clearmind Medicine Inc. on this page are Iroquois Capital Management, LLC (9.99%) and Richard Abbe (9.99%).
When did Iroquois Capital Management, LLC buy into Clearmind Medicine Inc.?
The filings give report dates, not purchase dates. The earliest filing from Iroquois Capital Management, LLC on this page is the Schedule 13G/A, filed 2026-08-12, reporting 9.99%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Clearmind Medicine Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Clearmind Medicine Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Clearmind Medicine Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Clearmind Medicine Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- HRT Financial LP, a 10% owner: 81,353 shares (51.5% of shares outstanding) (Form 4, 2026-06-18).
Shares outstanding: 158,076 as of 2026-01-19, from the company's latest SEC cover page.
How much has Clearmind Medicine Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-02-07 | $2.40M | $2.40M |
Latest IPO step: Clearmind Medicine Inc. amended its IPO registration (F-1/A, 2025-12-05).
IPO filings: F-1/A, 2025-12-05, F-1, 2025-11-26, F-1, 2025-09-19.
Keep reading
More on Clearmind Medicine Inc. and the records around it.
Clearmind Medicine Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- Capitalink Ltd. also filed stake reports on 3 other companies: QUANTUM X LABS INC. (May 2026)
- Nissim Daniel also filed stake reports on 5 other companies: QUANTUM X LABS INC. (Aug 2026)
- AdvisorShares Trust also filed stake reports on 8 other companies: Neuphoria Therapeutics Inc. (Oct 2026), PSYENCE BIOMEDICAL LTD. (Oct 2026), Silo Pharma, Inc. (Jul 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/clearmind-medicine